Intriguingly, analysis of the immunoglobulin heavy chain (IGHV) gene repertoire points toward a possible role for chronic (super) antigen-dependent BCR activation in a subset of ABC DLBCL and MCL patients [6, 7]. This evidence concerns the gene BCR and diffuse large B-cell lymphoma.